First Dollar Coverage for Chronic Disease Care: Can it Save Money and Improve Patient Outcomes?
Benefit-based interventions to address chronic disease compliance generally involve one of two approaches. The most common strategy is to exempt classes of drugs from copayments or coinsurance; a less tested strategy is to exempt classes of patients (i.e., diabetics) from cost sharing. Do such interventions improve health outcomes, and do they save money?